Li Junmin: Clinical Trials

1 trial sponsored by Li Junmin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Withdrawn 1

Follow Li Junmin: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)
Decitabine, Arsenic Trioxide - Myelodysplastic Syndromes, P53 Mutation
Phase 3WithdrawnLi Junmin2018-03-202023-08-16

Conditions studied

Myelodysplastic Syndromes (1)

Interventions

Arsenic (1)  ·  Arsenic Trioxide (1)  ·  Decitabine (1)

Countries

China (1)

Top investigators

Lu Min (1)  ·  Zhang Sujiang (1)